AtriCure, Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-01-04

Reporting Person: Noznesky Justin J (SVP, Mktg & Business Develop)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-04	Common Stock	M	15000	$18.30	Acquired	66005	Direct
2021-01-04	Common Stock	S	15000	$53.57	Disposed	51005	Direct
2021-01-04	Common Stock	S	8397	$53.61	Disposed	42608	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Option (Right to Buy)	$18.30	M	15000	Disposed	2024-01-06	Common Stock (15000)	Direct

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: This transaction was executed in multiple trades at prices ranging from $52.67 to $55.65 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $52.83 to $55.65 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: These options were granted on January 6, 2014. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.